B Braun Company Profile

What is the competitive landscape for B BRAUN, and what generic alternatives to B BRAUN drugs are available?

B BRAUN has one hundred and seventeen approved drugs.

There are two US patents protecting B BRAUN drugs.

There are twenty-seven patent family members on B BRAUN drugs in twenty-seven countries and two hundred and thirty-nine supplementary protection certificates in sixteen countries.

Summary for B Braun

International Patents:	27
US Patents:	2
Tradenames:	225
Ingredients:	63
NDAs:	117

Drugs and US Patents for B Braun

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	dextrose; potassium chloride; sodium chloride	INJECTABLE;INJECTION	019630-023	Feb 17, 1988		RX	No	No
B Braun Medical Inc	MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER	magnesium sulfate	INJECTABLE;INJECTION	207966-001	Oct 27, 2020	AP	RX	No	No
B Braun	ISOLYTE M W/ DEXTROSE 5% IN PLASTIC CONTAINER	dextrose; potassium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride	INJECTABLE;INJECTION	018270-001	Approved Prior to Jan 1, 1982		DISCN	No	No
B Braun	DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER	calcium chloride; dextrose; magnesium chloride; sodium acetate; sodium chloride	SOLUTION;INTRAPERITONEAL	018807-001	Aug 26, 1983		DISCN	No	No
B Braun	NEPHRAMINE 5.4%	amino acids	INJECTABLE;INJECTION	017766-001	Approved Prior to Jan 1, 1982		DISCN	No	No

Expired US Patents for B Braun

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
B Braun	HEPATAMINE 8%	amino acids	INJECTABLE;INJECTION	018676-001	Aug 3, 1982	3,950,529
B Braun	UCEPHAN	sodium benzoate; sodium phenylacetate	SOLUTION;ORAL	019530-001	Dec 23, 1987	4,284,647

International Patents for B Braun Drugs

Country	Patent Number	Estimated Expiration
Spain	2441790
Croatia	P20131221
European Patent Office	1931304
Italy	MI20051633
Denmark	1931304

Supplementary Protection Certificates for B Braun Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2603514	C02603514/02	Switzerland		PRODUCT NAME: VABORBACTAM UND MEROPENEM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67797 01.07.2021
1175904	2007C/048	Belgium		PRODUCT NAME: ALENDRONATE DE SODIUM/COLECALCIFEROL; AUTHORISATION NUMBER AND DATE: EU/1/05/310/001 20050826
1183240	C 2010 011	Romania		PRODUCT NAME: INDACATEROL SI SARURILE SALE ACCEPTABILE FARMACEUTICINDACATEROL(R)-5-[2-(5,6-DIETIL-INDAN-2-ILAMINO]-1-HIDROXIETIL]-8-HIDROXI-1H-CHINOLIN-2-ONA; NATIONAL AUTHORISATION NUMBER: RO EU/1/09/593/001, RO EU/1/09/593/002, RO EU/1/09/593/003, RO EU/1/09/593/004, RO EU/1/09/593/005, RO EU/1/09/593/006, RO EU/1/09/593/007, RO EU/1/09/593/008, RO EU/1/09/593/009, RO EU/1/09/593/010; DATE OF NATIONAL AUTHORISATION: 20091130; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EMEA EU/1/09/593/001, EMEA EU/1/09/593/002, EMEA EU/1/09/593/003, EMEA EU/1/09/593/004, EMEA EU/1/09/593/005, EMEA EU/1/09/593/006, EMEA EU/1/09/593/007, EMEA EU/1/09/593/008, EMEA EU/1/09/593/009, E [...]
1425001	SPC/GB14/034	United Kingdom		PRODUCT NAME: VILANTEROL OR SALTS OR SOLVATES THEREOF (I.E., 4-((1R)-2-((6-(2-((2,6-DICHLOROBENZYL)OXY)ETHOXY)HEXYL)AMINO)-1-HYDROXYETHYL)-2-(HYDROXYMETHYL)PHENOL OR SALTS OR SOLVATES THEREOF); REGISTERED: UK EU/1/13/886/001 20131114; UK EU/1/13/886/002 20131114; UK EU/1/13/886/003 20131114; UK EU/1/13/886/004 20131114; UK EU/1/13/886/005 20131114; UK EU/1/13/886/006 20131114
1713823	1490064-1	Sweden		PRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• B Braun
• B Braun Medical Inc